Safety of Ertugliflozin as a Monotherapy for the Treatment of Type Ⅱ Diabetes: a Meta-Analysis

NI Qian, LI Ting,PEI Yi-fang,TAN Ling

Chinese Pharmaceutical Journal ›› 2019, Vol. 54 ›› Issue (15) : 1268-1275.

PDF(2322 KB)
PDF(2322 KB)
Chinese Pharmaceutical Journal ›› 2019, Vol. 54 ›› Issue (15) : 1268-1275. DOI: 10.11669/cpj.2019.15.015

Safety of Ertugliflozin as a Monotherapy for the Treatment of Type Ⅱ Diabetes: a Meta-Analysis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 54(15): 1268-1275 https://doi.org/10.11669/cpj.2019.15.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2322 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉